UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

Cancer medicine (Malden, MA), 2020-03, Vol.9 (6), p.1966-1977

2020

Volltextzugriff (PDF)

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

British journal of haematology, 2019-11, Vol.187 (3), p.364-371

2019

Volltextzugriff (PDF)

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions

Cancer medicine (Malden, MA), 2021-05, Vol.10 (9), p.3035-3044

2021

Volltextzugriff (PDF)

Treatment of diffuse large B‐cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP‐16)

Hematological oncology, 2019-04, Vol.37 (2), p.136-142

2019

Volltextzugriff (PDF)

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.e6898-n/a

2024

Volltextzugriff (PDF)

Thioredoxin‐1 as a biological predictive marker for selecting diffuse large B‐cell lymphoma patients for etoposide‐containing treatment

European journal of haematology, 2020-08, Vol.105 (2), p.156-163

2020

Volltextzugriff (PDF)

Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma

Histopathology, 2013-01, Vol.62 (2), p.326-333

2013

Volltextzugriff (PDF)

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R87-R87, Article R87

2011

Volltextzugriff (PDF)

Slug is associated with poor survival in squamous cell carcinoma of the lung

International journal of clinical and experimental pathology, 2014-01, Vol.7 (9), p.5846-5854

2014

Volltextzugriff (PDF)

Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas

Histopathology, 2014-09, Vol.65 (3), p.319-327

2014

Volltextzugriff (PDF)

Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma

European journal of haematology, 2008-10, Vol.81 (4), p.289-297

2008

Volltextzugriff (PDF)

Risk for distant recurrence of breast cancer detected by mammography screening or other methods

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (9), p.1064

2004

Volltextzugriff (PDF)

Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening

Clinical cancer research, 2008-07, Vol.14 (13), p.4103-4110

2008

Volltextzugriff (PDF)

Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study

European journal of haematology, 2016-05, Vol.96 (5), p.492-501

2016

Volltextzugriff (PDF)

Long-term prognosis of breast cancer detected by mammography screening or other methods

Breast cancer research : BCR, 2011-01, Vol.13 (6), p.R134-R134, Article R134

2011

Volltextzugriff (PDF)

The Value of Sequential Serum Measurements of Gelatinases and Tissue Inhibitors During Chemotherapy in Ovarian Cancer

Anticancer research, 2006-11, Vol.26 (6C), p.4779-4784

2006

Volltextzugriff (PDF)

Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma

Histopathology, 2013-09, Vol.63 (3), p.438-439

2013

Volltextzugriff (PDF)

Serum matrix metalloproteinase‐9 in head and neck squamous cell carcinomais a prognostic marker

International journal of cancer, 2005-09, Vol.116 (3), p.422-427

2005

Volltextzugriff (PDF)

High preoperative plasma TIMP‐1 is prognostic for early relapse in primary breast carcinoma

International journal of cancer, 2008-08, Vol.123 (4), p.846-851

2008

Volltextzugriff (PDF)

Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma

European journal of haematology, 2008-01, Vol.80 (1), p.46-54

2008

Volltextzugriff (PDF)

Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy

European journal of haematology, 2013-07, Vol.91 (1), p.29-36

2013

Volltextzugriff (PDF)

High Serum TIMP-1 is Associated with Adverse Prognosis in Endometrial Carcinoma

Anticancer research, 2008-09, Vol.28 (5A), p.2715-2719

2008

Volltextzugriff (PDF)

Tissue Inhibitor of Matrix Metalloproteinase-1 Is Prognostic in Head and Neck Squamous Cell Carcinoma: Comparison of the Circulating and Tissue Immunoreactive Protein

Clinical cancer research, 2005-05, Vol.11 (9), p.3257-3264

2005

Volltextzugriff (PDF)

Matrix Metalloproteinase-9 (MMP-9) Immunoreactive Protein in Urinary Bladder Cancer: A Marker of Favorable Prognosis

Anticancer research, 2008-05, Vol.28 (3B), p.1757-1761

2008

Volltextzugriff (PDF)

Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma

Acta obstetricia et gynecologica Scandinavica, 2010-03, Vol.89 (3), p.380-384

2010

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(109)
magazinearticle
(1)

Sprache

Englisch
(109)
Japanisch
(10)
Finnisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions

Treatment of diffuse large B‐cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP‐16)

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Thioredoxin‐1 as a biological predictive marker for selecting diffuse large B‐cell lymphoma patients for etoposide‐containing treatment

Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Slug is associated with poor survival in squamous cell carcinoma of the lung

Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas

Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma

Risk for distant recurrence of breast cancer detected by mammography screening or other methods

Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening

Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study

Long-term prognosis of breast cancer detected by mammography screening or other methods

The Value of Sequential Serum Measurements of Gelatinases and Tissue Inhibitors During Chemotherapy in Ovarian Cancer

Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma

Serum matrix metalloproteinase‐9 in head and neck squamous cell carcinomais a prognostic marker

High preoperative plasma TIMP‐1 is prognostic for early relapse in primary breast carcinoma

Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma

Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy

High Serum TIMP-1 is Associated with Adverse Prognosis in Endometrial Carcinoma

Tissue Inhibitor of Matrix Metalloproteinase-1 Is Prognostic in Head and Neck Squamous Cell Carcinoma: Comparison of the Circulating and Tissue Immunoreactive Protein

Matrix Metalloproteinase-9 (MMP-9) Immunoreactive Protein in Urinary Bladder Cancer: A Marker of Favorable Prognosis

Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma

Aktive Filter

Suchergebnisse filtern